BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 25742478)

  • 21. Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes.
    Cirstea IC; Gremer L; Dvorsky R; Zhang SC; Piekorz RP; Zenker M; Ahmadian MR
    Hum Mol Genet; 2013 Jan; 22(2):262-70. PubMed ID: 23059812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enlarged spinal nerve roots in RASopathies: Report of two cases.
    Leoni C; Tedesco M; Talloa D; Verdolotti T; Onesimo R; Colosimo C; Flex E; De Luca A; Tartaglia M; Rigante D; Zampino G
    Eur J Med Genet; 2021 Apr; 64(4):104187. PubMed ID: 33676063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodevelopmental Aspects of RASopathies.
    Kim YE; Baek ST
    Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618
    [No Abstract]   [Full Text] [Related]  

  • 24. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone resorption in syndromes of the Ras/MAPK pathway.
    Stevenson DA; Schwarz EL; Carey JC; Viskochil DH; Hanson H; Bauer S; Weng HY; Greene T; Reinker K; Swensen J; Chan RJ; Yang FC; Senbanjo L; Yang Z; Mao R; Pasquali M
    Clin Genet; 2011 Dec; 80(6):566-73. PubMed ID: 21204800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
    Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
    Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASopathies Are Associated With Delayed Puberty; Are They Associated With Precocious Puberty Too?
    van der Kaay DC; Levine BS; Doyle D; Mendoza-Londono R; Palmert MR
    Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan.
    Lee CL; Tan LTH; Lin HY; Hwu WL; Lee NC; Chien YH; Chuang CK; Wu MH; Wang JK; Chu SY; Lin JL; Lo FS; Su PH; Hsu CC; Ko YY; Chen MR; Chiu HC; Lin SP
    Am J Med Genet A; 2020 Feb; 182(2):357-364. PubMed ID: 31837205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral profile in RASopathies.
    Alfieri P; Piccini G; Caciolo C; Perrino F; Gambardella ML; Mallardi M; Cesarini L; Leoni C; Leone D; Fossati C; Selicorni A; Digilio MC; Tartaglia M; Mercuri E; Zampino G; Vicari S
    Am J Med Genet A; 2014 Apr; 164A(4):934-42. PubMed ID: 24458522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LYMPHODYSPLASIA AND KRAS MUTATION: A CASE REPORT AND LITERATURE REVIEW.
    Morcaldi G; Bellini T; Rossi C; Maghnie M; Boccardo F; Bonioli E; Bellini C
    Lymphology; 2015 Sep; 48(3):121-7. PubMed ID: 26939159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
    Nava C; Hanna N; Michot C; Pereira S; Pouvreau N; Niihori T; Aoki Y; Matsubara Y; Arveiler B; Lacombe D; Pasmant E; Parfait B; Baumann C; Héron D; Sigaudy S; Toutain A; Rio M; Goldenberg A; Leheup B; Verloes A; Cavé H
    J Med Genet; 2007 Dec; 44(12):763-71. PubMed ID: 17704260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthopaedic conditions in Ras/MAPK related disorders.
    Reinker KA; Stevenson DA; Tsung A
    J Pediatr Orthop; 2011; 31(5):599-605. PubMed ID: 21654472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.
    Myers A; Bernstein JA; Brennan ML; Curry C; Esplin ED; Fisher J; Homeyer M; Manning MA; Muller EA; Niemi AK; Seaver LH; Hintz SR; Hudgins L
    Am J Med Genet A; 2014 Nov; 164A(11):2814-21. PubMed ID: 25250515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies.
    Rauen KA; Banerjee A; Bishop WR; Lauchle JO; McCormick F; McMahon M; Melese T; Munster PN; Nadaf S; Packer RJ; Sebolt-Leopold J; Viskochil DH
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):136-46. PubMed ID: 21495172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new "rasopathy": mutation in the CBL tumour-suppressor gene in neuro-cardio-facio-cutaneous syndrome similar to Noonan syndrome].
    Dereure O
    Ann Dermatol Venereol; 2011 Jan; 138(1):75-6. PubMed ID: 21276471
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
    Seemanová E; Zenker M
    Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy.
    Ezquieta B; Santomé JL; Carcavilla A; Guillén-Navarro E; Pérez-Aytés A; Sánchez del Pozo J; García-Miñaur S; Castillo E; Alonso M; Vendrell T; Santana A; Maroto E; Galbis L
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):447-55. PubMed ID: 22465605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?
    Nowaczyk MJ; Thompson BA; Zeesman S; Moog U; Sanchez-Lara PA; Magoulas PL; Falk RE; Hoover-Fong JE; Batista DA; Amudhavalli SM; White SM; Graham GE; Rauen KA
    Clin Genet; 2014 Feb; 85(2):138-46. PubMed ID: 23379592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The heart in RASopathies.
    Delogu AB; Limongelli G; Versacci P; Adorisio R; Kaski JP; Blandino R; Maiolo S; Monda E; Putotto C; De Rosa G; Chatfield KC; Gelb BD; Calcagni G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):440-451. PubMed ID: 36408797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.